Allarity Therapeutics, Inc. Amortization of Debt Discount (Premium)
Allarity Therapeutics, Inc. (ALLR) reported Amortization of Debt Discount (Premium) of $10.00 thousand for the 6-month period ending 2023-06-30, per its 10-Q filed 2024-08-05.
Discontinued › Cash Flow › Operating Activities
us-gaap:AmortizationOfDebtDiscountPremium · last filed 2024-08-05
- Allarity Therapeutics, Inc. amortization of debt discount (premium) for the quarter ending 2023-06-30 was $0.00.
- Allarity Therapeutics, Inc. amortization of debt discount (premium) for the quarter ending 2023-03-31 was $10.00K.
| Period end | Amortization of Debt Discount (Premium) 3 month | Amortization of Debt Discount (Premium) 6 month | Amortization of Debt Discount (Premium) 12 month |
|---|---|---|---|
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | $10.00K 10-Q · filed 2024-08-05 | |
| 2023-03-31 | $10.00K 10-Q · filed 2024-05-14 | ||
| 2022-12-31 | $34.00K 10-Q · filed 2023-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |